Watch the TriangleThis is one of the better looking drug stocks. There is very little resistance over the trendline.Longby KRSCBOE116
Expected Major Breakout With 50% On This Stock...After extensive research, I believe Sarepta Therapeutics Inc (NASDAQ:SRPT) will likely breakout this week. The chart has consolidated for a long period, slowly falling from over $60 after the last fantastic bit of drug news. The breakout trend line seen in the chart below continues to be hammered and should give way on the next move up. I also believe there will be likely drug news in the next few weeks which will propel the stock to as high as $45. That is a 50% upside target. This company is on the cutting edge of multiple biotech drug treatments and at its current valuation, offers an amazing opportunity. I am looking to buy some this week, the second the stock crosses above the breakout trend line. View my verified performance here: verifiedinvesting.comLongby jenny_rebekka116
Biotech $SRPT Crushed On Bigger Loss, See Buy Levels HereAfter the stock market closed on Tuesday, Sarepta Therapeutics Inc (NASDAQ:SRPT) reported a bigger-than-expected loss of $88.5 million or $1.62 per share. In addition, investors are questioning their ability to fully launch and profit from upcoming drugs, offsetting future losses as they burn through cash. The stock took a beating after-hours, dropping almost 15% to below $27 per shares. As investors are freaking out, those of us not currently invested in the stock have a chance to make a wise decision. The company still has huge drugs in its pipeline and over $300 million in cash. The key is finding the right buy level. The first major support on the stock is at $24.00. That would be the first spot to accumulate a small position. I would recommend accumulating all the way down to $20, then looking for positive drug news to drive the stock above $40. Stock chart analysis on Sarepta Therapeutics after crushedby AnnabelleTrader115
Possible Long OpportunityNASDAQ:SRPT is already almost oversold but I think $24.2 would be a good level to buy for a long position, lets see...by mrezaei2
$SRPT SRPT short tomorrow$SRPT SRPT If this baby gaps up tomorrow I'm going to go short if it spikes up into a whole dollar, then I will have my resistance right above thatShortby Livin1
OPENING: SRPT JAN 2017 8 LONG PUTShooting for an .08 ($8) debit fill here. It's a lotto trade (which I hardly ever do), but I think that the drug will ultimately not be approved. The potential profit is $795/contract, but that's if the stock goes to "0." Additionally, it will only "play out" if there is news prior to expiry. Otherwise, it'll stay way up here.by NaughtyPinesUpdated 2
Vega is the candyIV at 303% when historical volatility barely makes it to 200% makes this trade a pretty easy one imo. There's a very minimal chance that a gap would find higher values of $40 - or less than $4. Anyway, I'm not holding this options once the theta fat is gone. Sarepta Therapeutics: Patience Will Not Be Rewarded Stock Falls, Janney: 'Stay on the Sidelines'by Ice_Updated 2
SOLD SRPT AUG 26TH 35 CALL... for a 2.85 ($285)/contract credit. This will complete an Aug 26th 10/35 short strangle worth 4.15 in credit ($415)/contract, which I'll shoot to take off at 50% max profit. Because I already had the 10 short put on, this doesn't cost me any additional buying power. This will also give me some protection to the short side, since I think that this is more likely to implode than explode. Naturally, I hope to be out before any of that "splosion" occurs.by NaughtyPinesUpdated 993
BOUGHT TO COVER SRPT SEPT 16TH 8/40 SHORT STRANGLEMmm. Must have gotten busy and not posted this one. In any event, I legged into these two sides separately, the 8 first and then the 40 after it ripped somewhat higher. The whole burrito was worth 5.82 in credito. Closing out here for a 4.60 debit nets me $122/contract in profit. This thing is "wicked illiquid", so I figured I get while the gettin' was good ... .by NaughtyPines2
$SRPT chart pivot pointchart gets interesting at $24 from a technical perspective. Watching.Longby Carr4
PREMIUM SELLING: SOLD SRPT AUG 26TH 10 SHORT PUT... for a 1.30 ($130)/contract credit. I probably could have worked for a better fill by $5-$10, but wanted to get this last trade on before the close. Metrics: Probability of Profit: 86% Max Profit: $130/contract Max Loss: Undefined Buying Power Effect: $100/contract Break Even: 8.70 Notes: I'll look to take this off at 50% max. It's a trade, not an investment ... .Longby NaughtyPines0
SPRT- Bought Jan17- 30 Option callsSeems breaking up a symmetrical triangle, money-flow in strong. Waiting for a big announcement, so we took some speculative Option calls. For trade we took some Jan17- 30 call for $6 Longby AcornWealthCorp1
No clear trendChart is not looking bullish or aggressively bearish, needs to start building higher lows if it wants to fill the gap to $30.by stocknique1